Buyout giants in talks with Wockhardt for domestic formulations business

The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news